1. Executive Summary
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.2. Forecast Factors – Relevance & Impact
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Trends
4. Key Success Factors
5. Global Market Volume Analysis 2018-2022 and Forecast, 2023-2033
5.1. Historical Market Volume (‘000 Units) Analysis, 2018-2022
5.2. Current and Future Market Volume (‘000 Units) Projections, 2023-2033
6. Global Market – Pricing Analysis
7. Global Market Value Analysis 2018-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2018 – 2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023 – 2023
8.3.1. 1- Panel Saliva Drug Test Kits
8.3.2. 4- Panel Saliva Drug Test Kits
8.3.3. 5- Panel Saliva Drug Test Kits
8.3.4. 6- Panel Saliva Drug Test Kits
8.3.5. 7- Panel Saliva Drug Test Kits
8.3.6. 8- Panel Saliva Drug Test Kits
8.3.7. 9- Panel Saliva Drug Test Kits
8.3.8. 10- Panel Saliva Drug Test Kits
8.3.9. 12- Panel Saliva Drug Test Kits
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Form
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Form, 2018 – 2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2023 – 2033
9.3.1. Cassettes
9.3.2. Swabs
9.3.3. Strips
9.4. Market Attractiveness Analysis By Form
10. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Drug Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2018 – 2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2023 – 2023
10.3.1. Alcohol
10.3.2. Marijuana (THC)
10.3.3. Opioids
10.3.4. Cocaine
10.3.5. Amphetamines
10.3.6. Methamphetamines
10.3.7. Benzodiazepines
10.3.8. Others
10.4. Market Attractiveness Analysis By Drug Type
11. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 – 2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2023
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Forensic Laboratories
11.3.4. Private Employers
11.3.5. Home Care Settings
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 – 2022
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 – 2023
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. East Asia
12.3.6. South Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. By Form
13.3.4. By Drug Type
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints – Impact Analysis
14. Latin America Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product Type
14.3.3. By Form
14.3.4. By Drug Type
14.3.5. By End User
14.4. Market Attractiveness Analysis
15. Europe Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. Rest of Europe
15.3.2. By Product Type
15.3.3. By Form
15.3.4. By Drug Type
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. South Asia Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product Type
16.3.3. By Form
16.3.4. By Drug Type
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. East Asia Market Analysis 2018-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product Type
17.3.3. By Form
17.3.4. By Drug Type
17.3.5. By End User
17.4. Market Attractiveness Analysis
18. Oceania Market Analysis 2018-2022 and Forecast 2023-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product Type
18.3.3. By Form
18.3.4. By Drug Type
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Rest of Middle East and Africa
19.3.2. By Product Type
19.3.3. By Form
19.3.4. By Drug Type
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints – Impact Analysis
20. Market Structure Analysis
20.1. Tier Structure Analysis (2022)
20.2. Company Share Analysis, By Top Players (2022)
20.3. Competition Benchmarking
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Abbott Laboratories
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Analyst Commentary
21.2.1.4. Key Financials
21.2.1.5. Key Developments
21.2.2. Guangzhou Wondfo Biotech Co., Ltd
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Analyst Commentary
21.2.2.4. Key Financials
21.2.2.5. Key Developments
21.2.3. OraSure Technologies, Inc
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Analyst Commentary
21.2.3.4. Key Financials
21.2.3.5. Key Developments
21.2.4. Oranoxis Inc
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Analyst Commentary
21.2.4.4. Key Financials
21.2.4.5. Key Developments
21.2.5. Premier Biotech, Inc
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Analyst Commentary
21.2.5.4. Key Financials
21.2.5.5. Key Developments
21.2.6. UCP Biosciences, Inc.
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Analyst Commentary
21.2.6.4. Key Financials
21.2.6.5. Key Developments
21.2.7. SCREEN ITALIA SRL
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Analyst Commentary
21.2.7.4. Key Financials
21.2.7.5. Key Developments
21.2.8. Securetec Detektions-Systeme AG
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Analyst Commentary
21.2.8.4. Key Financials
21.2.8.5. Key Developments
21.2.9. MEDACX Ltd.
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Analyst Commentary
21.2.9.4. Key Financials
21.2.9.5. Key Developments
21.2.10. AccuBioTech Co. Ltd.
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Analyst Commentary
21.2.10.4. Key Financials
21.2.10.5. Key Developments
22. Assumptions and Acronyms Used
23. Research Methodology
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer